ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves Initiation of IGC’s Cannabinoid Trial on Alzheimer’s Patients
August 19, 2020The U.S. Food and Drug Administration (FDA) notified India Globalization Capital (IGC) it has authorized the initiation Phase 1 human trial study for the Company’s investigational cannabinoid formulation for the treatment of patients suffering from ...
Pharma Sources Insight January 2025
